News

The FDA Office of Orphan Products Development (OOPD) mission is to advance the evaluation and development of products that show promise for the diagnosis and/or treatment of rare

As part of the deal, Lee’s Pharma will have exclusive rights to develop and commercialize the antibody for the Chinese market, including Mainland China, Hong Kong, Macau, and

The acquisition will see ClinIntel’s offerings combined into the ClinPhone RTSM suite and are designed to make patient randomization and clinical supply chain solutions more efficient. ClinIntel’s capabilities

Under the terms of the agreement, Baxter will become the exclusive distributor of Rockwell’s hemodialysis concentrate and ancillary products in the U.S. and selected foreign countries for an

"We are pleased to enter into this strategic partnership and are excited by the opportunity to couple Intrexon’s market-leading expertise in synthetic biology with our proficiency in cell

The United States ("U.S.") Patent and Trademark Office has granted its sixth patent and the Japan Patent Office has granted its first patent for the Company’s lead oncology

The facility will be used to support automated production of the company’s Arcelis-based personalized immunotherapy product candidates, beginning with AGS-003, the company’s lead oncology product candidate, currently being

Currently, there are no approved treatments for FA, which is a debilitating, life-shortening, degenerative neuro-muscular disorder affecting at least one in 50,000 people in the US. Most youngsters

The humanized monoclonal antibody, RPC4046 is directed against interleukin-13 (IL-13), a target which has been validated in other related allergic indications. Receptos president and chief executive officer Faheem